Herb ·Emerging evidence ·Reviewed May 2026
Pueraria mirifica is a Thai tuber used in supplements for menopausal vasomotor, vaginal, skin, and breast-related claims because it contains potent phytoestrogens including miroestrol and deoxymiroestrol. Small clinical studies suggest possible benefit for menopausal symptoms and lipid markers, but evidence quality and long-term safety are limited. Because it has estrogenic activity, it is not appropriate for pregnancy, hormone-sensitive cancers, unexplained vaginal bleeding, or unsupervised use with hormone therapy.
The bottom line
Evidence rating emerging. Most-documented uses: may reduce menopausal symptom scores in small trials, may support vaginal dryness or urogenital symptoms in selected postmenopausal users, may modestly improve lipid markers. 3 sources indexed (2008–2018), with 3 interaction records on file.
Core mechanism
Isoflavones and chromenes in Pueraria mirifica can bind estrogen receptors and produce weak selective estrogenic effects in estrogen-responsive tissues. Miroestrol, deoxymiroestrol, coumestrol, daidzein, genistein, and puerarin may influence vasomotor symptoms, vaginal epithelium, bone turnover, and lipid handling, but potency and composition vary widely between products. The same estrogenic mechanism drives safety concerns in hormone-sensitive conditions and with other hormone-active products.3,1
Take with meals for tolerability. Product standardization is a major limitation because phytoestrogen content can vary by plant source, age, and extraction method.2
Ranked by evidence and value.
Real-world pricing across three quality tiers. Assumes Standardized root extract capsule.
Products with disclosed plant identity and standardization cost more but are safer to interpret. Updated 2026-06-04.
Timing: With the same meal daily
Assess after 8-12 weeks and stop if bleeding, breast symptoms, or no benefit occur.
Dose: 25 mg/day trial dose
Timing: With food
Evidence is limited; persistent genitourinary syndrome of menopause often responds better to clinician-directed local therapies.
Dose: 25-50 mg/day3
Timing: With meals
Do not use instead of proven lipid management when cardiovascular risk is elevated.
What to test, the optimal window inside the conventional range, and how long a response takes.
May modestly improve lipid markers in small postmenopausal studies, but not a primary lipid therapy.3
Use fasting or nonfasting lipid panel according to clinician preference.
Where this appears in the symptom-to-supplement map, ranked by relevance.
Phytoestrogen receptor activity may modulate vasomotor symptoms.3
Not a substitute for clinician-guided menopause therapy in severe symptoms.
Weak estrogenic activity may affect urogenital epithelium.3
Bleeding, pain, or recurrent infections need evaluation.
Estrogenic signaling may influence skin hydration, but direct evidence is limited.3
Cosmetic claims are often stronger than clinical evidence.
Both are used for hormone-related goals and may complicate assessment of breast, menstrual, prostate, or endocrine symptoms.
Recommendation: Avoid unsupervised hormone-active stacking; stop and seek care for bleeding, breast changes, or prostate red flags.
St. John's Wort may alter metabolism of many drugs and hormone therapies, making estrogenic supplement effects harder to predict.
Recommendation: Avoid combining when using hormonal contraception, hormone therapy, anti-estrogen drugs, or prescription medications without clinician review.
Ginkgo can increase bleeding tendency, and estrogenic botanicals can cause abnormal bleeding in susceptible users.
Recommendation: Avoid high-dose combination before surgery or in unexplained bleeding; seek care for vaginal bleeding after menopause.
Numbered references. Citations throughout the page link here.
Small clinical trials suggested possible menopausal symptom benefit but highlighted the need for better long-term safety and standardization.
Both 25 mg and 50 mg daily were associated with symptom score improvement over 6 months in postmenopausal women.
A small trial reported lipid changes consistent with estrogenic activity.
This page is educational. Do not start, stop, or change a supplement or medication based on it without checking with a qualified healthcare professional.
Use this with your stack
Add it to your stack, see how it interacts with everything else you take, and get a Stack Score that updates the moment it does.
NutriStack is an informational and organizational tool, not a medical service, and not a substitute for professional advice. Always consult a qualified healthcare professional before starting, stopping, or changing any supplement or medication.
